|
Volumn 30, Issue 1, 2002, Pages 100-106
|
A phase II randomized, controlled trial of continuous hemofiltration in sepsis
e
NONE
|
Author keywords
Anaphylatoxins; Complement; Cytokines; Hemofiltration; Interleukin 10; Interleukin 6; Interleukin 8; Multiple organ failure; Septic shock; Tumor necrosis factor
|
Indexed keywords
ANAPHYLATOXIN;
COMPLEMENT COMPONENT C3A;
COMPLEMENT COMPONENT C5A;
CYTOKINE;
INTERLEUKIN 10;
INTERLEUKIN 6;
INTERLEUKIN 8;
TUMOR NECROSIS FACTOR ALPHA;
ACUTE KIDNEY FAILURE;
ADULT;
AGED;
ARTICLE;
ARTIFICIAL VENTILATION;
BLOOD OXYGENATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DISEASE COURSE;
FEMALE;
FLUID THERAPY;
HEMOFILTRATION;
HUMAN;
INFLAMMATION;
MALE;
MULTIPLE ORGAN FAILURE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTRICTION MAPPING;
SCORING SYSTEM;
SEPSIS;
SEPTIC SHOCK;
THROMBOCYTE COUNT;
|
EID: 0036154952
PISSN: 00903493
EISSN: None
Source Type: Journal
DOI: 10.1097/00003246-200201000-00016 Document Type: Article |
Times cited : (252)
|
References (17)
|